Transthyretin amyloid cardiomyopathy - tafamidis - initial authority application form (PB358)

Use this form to apply for initial PBS-subsidised treatment or initial grandfathered PBS-subsidised treatment with tafamidis for patients with transthyretin amyloid cardiomyopathy.

Page last updated: 1 November 2024.
QC 65883